Cardiology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Heart. 2018 Jan;104(2):151-160. doi: 10.1136/heartjnl-2017-311435. Epub 2017 Aug 30.
A systematic summary of the observational studies informing heart transplant guideline recommendations for selection of candidates and donors has thus far been unavailable. We performed a meta-analysis to better understand the impact of such known risk factors.
We systematically searched and meta-analysed the association between known pretransplant factor and 1-year mortality identified by multivariable regression models. Our review used the Grading of Recommendations, Assessment, Development and Evaluation for assessing the quality of assessment. We pooled risk estimates by using random effects models.
Recipient variables including age (HR 1.16 per 10-year increase, 95% CI 1.10-1.22, high quality), congenital aetiology (HR 2.35, 95% CI 1.62 to 3.41, moderate quality), diabetes (HR 1.37, 95% CI 1.15 to 1.62, high quality), creatinine (HR 1.11 per 1 mg/dL increase, 95% CI 1.06 to 1.16, high quality), mechanical ventilation (HR 2.46, 95% CI 1.48 to 4.09, low quality) and short-term mechanical circulatory support (MCS) (HR 2.47, 95% CI 1.04 to 5.87, low quality) were significantly associated with 1-year mortality. Donor age (HR 1.20 per 10-year increase, 95% CI 1.14 to 1.26, high quality) and female donor to male recipient sex mismatch (HR 1.38, 95% CI 1.06 to 1.80, high quality) were significantly associated with 1-year mortality. None of the operative factors proved significant predictors.
High-quality and moderate-quality evidence demonstrates that recipient age, congenital aetiology, creatinine, pulsatile MCS, donor age and female donor to male recipient sex mismatch are associated with 1-year mortality post heart transplant. The results of this study should inform future guideline and predictive model development.
目前,尚缺乏系统总结用于指导心脏移植候选人及供体选择的观察性研究的文献。本研究进行了一项荟萃分析,以更好地了解这些已知危险因素的影响。
我们系统地检索并荟萃分析了多变量回归模型确定的已知移植前因素与 1 年死亡率之间的关联。我们的综述使用推荐分级、评估、发展与评价(Grading of Recommendations, Assessment, Development and Evaluation,GRADE)来评估评估质量。我们使用随机效应模型汇总风险估计值。
受者变量包括年龄(每增加 10 岁,HR 为 1.16,95%CI 为 1.10-1.22,高质量)、先天性病因(HR 为 2.35,95%CI 为 1.62-3.41,中质量)、糖尿病(HR 为 1.37,95%CI 为 1.15-1.62,高质量)、肌酐(HR 为每增加 1mg/dL,1.11,95%CI 为 1.06-1.16,高质量)、机械通气(HR 为 2.46,95%CI 为 1.48-4.09,低质量)和短期机械循环支持(mechanical circulatory support,MCS)(HR 为 2.47,95%CI 为 1.04-5.87,低质量)与 1 年死亡率显著相关。供者年龄(每增加 10 岁,HR 为 1.20,95%CI 为 1.14-1.26,高质量)和女性供者-男性受者性别不匹配(HR 为 1.38,95%CI 为 1.06-1.80,高质量)与 1 年死亡率显著相关。没有任何手术因素被证明是显著的预测因子。
高质量和中质量证据表明,受者年龄、先天性病因、肌酐、搏动性 MCS、供者年龄和女性供者-男性受者性别不匹配与心脏移植后 1 年死亡率相关。本研究的结果应为未来指南和预测模型的制定提供信息。